Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systems medicine analysis of sarcoidosis by targeting mTOR with sirolimus
2017-004930-27Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sirolimus in sarcoidosis, sponsored by Medical University of Vienna. Primary endpoints: Treatment efficacy (improvement or stabilization of sarcoidosis) and Safety and tolerability of sirolimus. Started Dec 2018; status: terminated.
02
Drugs
sirolimus
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on 2017-004930-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004930-27.